Back to calendar
Evommune, Inc. (EVMN) Earnings
EVMN reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.66
Actual EPS: $-0.64
EPS surprise: 21.28%
Company overview
Market Cap$408.8M
PriceUSD 11.35
EPS (TTM)-2.39
52-week high33.20
52-week low10.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees48